Lord Prior of Brampton
Chair - NHS England
Lord Prior has been Chairman of NHS England since October 2018.
He was educated at Cambridge University and subsequently qualified as a barrister. He trained in finance at Lehman Brothers and Lazard Freres in New York before holding a number of senior positions within the industrial sector, including British Steel, where he was Commercial Director. He was elected MP for North Norfolk in 1997.
He served as Chairman of Norfolk and Norwich University Hospitals NHS Foundation Trust from 2002 – 2012 before becoming Chairman of the Care Quality Commission.
In 2015, he was appointed Parliamentary Under Secretary of State for Health and created a Life Peer. In December 2016, he was appointed as Parliamentary Under Secretary of State at the Department of Business, Energy & Industrial Strategy, with specific responsibility for developing industrial strategy. He stepped down from this role in October 2017 to become Chairman of University College London Hospitals.
He is also Deputy Chairman at Lazard.
Alan Gemmell O.B.E
Her Majesty's Trade Commissioner, South Asia and British Deputy High Commissioner - Western India
Alan was appointed Her Majesty’s Trade Commissioner for South Asia and the British Deputy High Commissioner for Western India in June 2020.
Prior to his appointment, he was Chief Executive of the Commonwealth Enterprise and Investment Council where he promoted intra-Commonwealth trade working with leading British businesses including: HSBC, JCB, Rolls Royce, Standard Chartered, as well as the City of London, the UK government and a number of governments of Commonwealth countries. Alan was part of a 2019 Commonwealth mission to assess the successful application of the government of Maldives to re-join the Commonwealth.
Alan has worked in Brazil, India, Israel and Mexico with the British Council and was Director of the British Council in India from 2016 to 2018 leading the UK-India Year of Culture and working with State Governments to support education agendas across the country. He has also worked on counter terrorism and preventing extremism in the UK’s Cabinet Office and on economic migration in the Home Office and was awarded an Order of the British Empire (OBE) in the 2016 New Year’s Honours list for services to arts and science.
Alisha Moopen
Deputy Managing Director, Aster DM Healthcare
Alisha Moopen is the Deputy Managing Director of Aster DM Healthcare, managing the company’s operations in India and the GCC. Having joined the company as a Director in 2013, she is responsible for overseeing the strategic direction and development of the company, and notably spearheading the expansion of the group into new markets.
Aster DM Healthcare is one of the largest integrated healthcare conglomerate with a presence across 7 countries. With 34 years of strong track record of providing compassionate care to patients, Aster provides the complete circle of care through its primary, secondary, tertiary and quaternary care services, and its network of 27 hospitals, 126 clinics/ labs and over 300 pharmacies. The organisation currently employs more than 22,000 people, of which 3000+ are doctors and 6500+ are nursing staff.
Alisha was elected by World Economic Forum as a Young Global Leader to join the class of 2018. Recognising her past work in healthcare, she has been inducted into a 5-year programme with like-minded people who are committed and passionate to tackle the main challenges of the world today, with healthcare being one of them. She has also been appointed to the Board of YPO’s Dubai Chapter, a global leadership organization that brings together over 27,000 chief executives from over 130 countries. She is currently serving as the Learning Officer at YPO. She is the Founder and Vice-Chairwoman of Dubai Healthcare Business Group. In 2021, she was also appointed to the Board of Thought Leadership and Innovation Foundation, a US based Non-profit organization, recently.
In 2021, Alisha was awarded by Harvard Business Council with the International Executive’s award, Gold award by Stevie Awards for Women in Business and Entrepreneur India’s Entrepreneur of the Year Award in Service Business – Healthcare category. In 2020, she was recognized as one of the Most Influential Women in the Arab World by CEO Middle East Magazine. She has also been featured in Business Today's Most Powerful Women list 2019. She was also recognised as one of the Top 100 World’s Greatest Leaders in Asia and GCC in 2018. Forbes Middle East magazine has selected Alisha as one of the Top Next Generation Indian Leaders in 2018. She has also won Khaleej Times’ Emerging Leaders Award for Healthcare, The Asian Business Leadership Forum’s (ABLF) Rising Star Award, Game Changer of the Year Award at Global Women in Leadership Economic Forum and Emirates Woman Magazine’s Woman of the Year Award in the Achiever category; all in 2018.
She is a Chartered Accountant from the ICAS (Institute of Chartered Accountants of Scotland) and worked earlier with Ernst & Young. She graduated from the University of Michigan, Ann Arbor with distinction in Finance & Accounting. She also holds a degree in Global Leadership & Public Policy Change from Harvard University. Alisha Moopen's philosophy in life is 'Healthiness is Happiness'. She wants to enable quality healthcare across the globe through treating people with compassion, precision and excellence. She is dedicated to the cause of women empowerment and mental health. She believes in the diversity of workforce, strength in differences and focused on improving the glass ceilings at work for women. She was instrumental in launching the Women in Leadership programme at Aster DM Healthcare which empowers talented and capable female employees with training and growth opportunities, to shape them for leadership roles.
She is also an active philanthropist, being a trustee of Aster DM Foundation and involved in social welfare through Aster Volunteers programme which bridges the gap between people who would like to help with those in need. Health is a birth right of every human on this planet. Alisha is dedicated to ensure that humanity leverages on advances in science as well as personal re-engineering of self, ranging from lifestyle choices to dealing with the external environment, to staying happy and healthy, both physically and mentally. She believes using technology can enable better health outcomes for population management through precision medicine, connected care and AI.
Professor Sarang Deo
Executive Director, Max Institute of Healthcare Management; Associate Professor, Operations Management, Indian School of Business
Prof. Deo’s primary area of interest is health care operations with special emphasis on investigating the impact of operations decisions on population level health outcomes. He has studied the influenza vaccine supply chain and the phenomenon of ambulance diversion (in the US), the adult HIV treatment supply chains and the infant HIV diagnosis networks in sub Saharan Africa, and more recently the TB diagnosis and treatment pathways in India. He frequently collaborates with international agencies such as the Clinton Health Access Initiative and the Bill and Melinda Gates Foundation and his research has been funded by the US National Science Foundation and Grand Challenges Canada.
Prior to joining the ISB, Sarang was Assistant Professor at the Kellogg School of Management. He was a management consultant in the Accenture’s Mumbai office before embarking on an academic career. Sarang has a PhD from UCLA Anderson School of Management, MBA from IIM Ahmedabad, and BTech from IIT Bombay.
Chris Born
Head of NHS Collaborative Exports, Healthcare UK
Chris is a former NHS CEO who has worked as a senior consultant specialist with Healthcare UK based at the Department for International Trade (DIT) for the last nine years. He was interim Managing Director in 2016.
Since January 2021, Chris has taken on the interim role as Head of NHS Collaborative Exports working with the Department of Health and Social Care, Healthcare UK and NHS England and NHS Improvement to agree the role and shape of the Collaborative with the NHS and healthcare Arm’s Length Bodies. The NHS Export Collaborative was announced in the NHS Long Term Plan to support Trusts, ALBs and other bodies to export UK innovations in healthcare.
Chris has worked with the NHS and commercial health and care organisations in the UK to make an integrated offer to operators, developers, investors, governments and health services in the target markets of India, China, SE Asia, the Middle East and other countries. Until January, he was the DIT Ambassador for the Ageing Society Grand Challenge of the UK government’s Industrial Strategy. He has been responsible for the development of a detailed set of UK offers, including clinical services (most recently diabetes, oncology, cardiac services and mental health), infrastructure, training and digital health.
Chris worked for 25 years in the NHS both in a Trust and as a commissioner. Chris also worked in a predecessor of NHS England and NHS Improvement (the NHS Executive) and in 2012 was seconded to the then Department of Health to develop NHS Global (which led to the creation of Healthcare UK).
Supported By
